What You Should Know
Weave Bio has expanded its AI-native regulatory platform to support New Drug Application (NDA) submissions, covering the full drug development lifecycle.Strategic partner Parexel co-developed and refined the platform, resulting in authoring speeds that are 60% faster than traditional manual methods.The platform utilizes AI-native data extraction, content verification, and automated authoring to synthesize clinical, non-clinical, and manufacturing data.Parexel will
Read More
Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations
What You Should Know
Moderna has selected Salesforce’s Agentforce Life Sciences to serve as its unified, global platform for commercial operations and customer engagement.The platform will consolidate data from SAP, ecommerce, and regional systems to create a single "Customer 360" source of truth for all healthcare provider (HCP) interactions.Field teams will utilize AI-powered agents to automate cycle planning, deliver "next best action" recommendations, and streamline real-time call
Read More
FDA Announces Real-Time Clinical Trial Pilot Program and Proof-of-Concept Studies with AstraZeneca and Amgen
What You Should Know
The FDA has launched two proof-of-concept (PoC) real-time clinical trials (RTCT) that report endpoints and data signals to the agency as they occur.AstraZeneca is leading a Phase 2 trial (TRAVERSE) for mantle cell lymphoma, while Amgen is conducting a Phase 1b trial (STREAM-SCLC) for small cell lung carcinoma.The initiative aims to eliminate the traditional "hiatus" between clinical phases, moving toward a model of "continuous" trials that reduces regulatory lag.A Request
Read More
Beth Israel Lahey Health Partners with Heidi to Deploy Ambient AI Scribing to All Physicians
What You Should Know
Beth Israel Lahey Health (BILH) is expanding its partnership with Heidi to provide ambient AI scribing capabilities to all of its more than 6,000 providers.An initial 6-month trial involving 1,000 providers resulted in 89% satisfaction regarding the quality of generated medical notes.The technology significantly impacts clinician well-being, with 82% of trial users reporting reduced cognitive load and 74% noting a reduction in time spent working outside of standard
Read More
Koda Health Secures Investment from UPMC Enterprises for AI-Enhanced Advance Care Planning Platform
What You Should Know
The Investment: Koda Health secured a Series A strategic investment from UPMC Enterprises to aggressively scale its AI-enhanced Advance Care Planning (ACP) platform across complex patient populations.The Financial Toll: The American healthcare system currently spends an estimated $200 billion annually on care that patients would not have wanted had they been engaged in care planning earlier in their journey.The Technology Engine: The platform navigates patients through
Read More
Covera Health and Medmo Combine to Launch Nationwide AI Diagnostic Imaging and Care Coordination Platform
What You Should Know
Covera Health and Medmo have officially merged into a single organization, creating a unified platform that manages diagnostic imaging for nearly 6 million Americans.The combined entity is backed by additional capital from Insight Partners and serves major clients, including Walmart, Blue Cross Blue Shield of Michigan, and three of the five largest national health plans.Covera’s AI-driven platform focus on diagnostic accuracy has produced up to 12 percent lower downstream
Read More
Availity Abrasion Index 2026: Denials and Prior Authorization Top Payer-Provider Friction Points
What You Should Know
Availity has launched the 2026 Abrasion Index, a dual-sided research report quantifying administrative friction between U.S. health plans and healthcare providers.Denials emerged as the most severe abrasion point, with the report finding that ~70% of denials are ultimately overturned and paid, creating significant administrative "churn".Prior authorization remains a critical burden, with physicians averaging 13 hours per week on the process and 89% reporting it
Read More
TytoCare Receives FDA De Novo Classification for Tyto Insights ENT Suite AI Image Analysis
What You Should Know
TytoCare has received FDA De Novo classification for its Tyto Insights™ for ENT Suite, creating a first-of-its-kind regulatory category for "ear, nose, and throat image analyzers".The AI-powered tool automatically analyzes otoscopy video to detect eardrum bulging, a primary indicator of Acute Otitis Media and other common pediatric conditions.Designed for patients aged six months and older, the system uses a proprietary database of 1.6 million ear images to provide
Read More
Auxira Health and St. Luke’s University Health Network Partner to Expand Virtual Cardiology Support
What You Should Know
St. Luke’s University Health Network (SLUHN) is collaborating with Auxira Health to integrate virtually-embedded teams into its Heart & Vascular network.The model provides each cardiologist with a virtual support team of nurse practitioners, medical assistants, and registered nurses to manage follow-ups and care coordination.The initiative launches with 24 cardiologists, with established plans to expand across multiple St. Luke’s locations in Pennsylvania and New
Read More
Accenture Ventures Invests in Iridius to Scale Compliant-by-Design AI for Life Sciences and Pharmaceuticals
What You Should Know
Accenture Ventures has made a strategic investment in Iridius, an enterprise AI infrastructure company specializing in compliant-by-design solutions for highly regulated industries.The partnership will build end-to-end compliance workflows across the life sciences value chain, covering regulatory submissions, pharmacovigilance, and clinical operations.Iridius technology uses a knowledge engine to translate complex global regulatory standards into machine-readable logic,
Read More
